Literature DB >> 2160354

Effect of lithium on the renal actions of alpha-human atrial natriuretic peptide in normal man.

S Freestone1, R F Jeffrey, C V Bonner, M R Lee.   

Abstract

1. alpha-Human atrial natriuretic peptide (7.5 pmol min-1 kg-1) was infused intravenously into eight healthy men after pretreatment with lithium carbonate (750 mg) or placebo. 2. Baseline sodium excretion was significantly increased after lithium, but the natriuresis during infusion of alpha-human atrial natriuretic peptide was attenuated. 3. Similar decreases in plasma renin activity with infusion of alpha-human atrial natriuretic peptide occurred on both days. 4. Administration of lithium may be associated with pharmacological effects and further work is required to validate the use of lithium clearance as a marker of proximal renal tubular sodium handling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160354     DOI: 10.1042/cs0780371

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.

Authors:  M R Wilkins; S L Settle; J E Kirk; S A Taylor; K P Moore; R J Unwin
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

2.  Lithium does not alter the renal response to a pressor dose of tyramine in man.

Authors:  C C Lang; A R Rahman; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

3.  Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome.

Authors:  T W Mackay; M F Fitzpatrick; S Freestone; M R Lee; N J Douglas
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.